Quantum Biopharma (QNTM) Research & Development (2020 - 2026)
Quantum Biopharma (QNTM) reported Research & Development of $626092.0 for Q1 2026, down 62.02% on a YoY basis from $1.6 million in Q1 2025, and up 789.28% sequentially from $70404.0 in Q4 2025.
Quantum Biopharma (QNTM) Research & Development (2020 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 7 years of Research & Development data on file, last reported at $626092.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 62.02% year-over-year to $626092.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 49.56% YoY), and the FY2025 full-year result was $2.8 million, down 54.58% from the prior year.
- Research & Development improved to $626092.0 in Q1 2026, from $70404.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $2.3 million in Q1 2023 to a low of $32985.0 in Q3 2023.
- A 5-year average of $719517.2 and a median of $587644.5 in 2025 frame the typical range for Research & Development.
- Peak annual rise in Research & Development reached 2158.0% in 2024, while the deepest fall reached 93.07% in 2024.
- Tracing QNTM's Research & Development over 5 years: stood at $937052.0 in 2022, then sank by 96.48% to $32985.0 in 2023, then jumped by 385.86% to $160260.0 in 2024, then tumbled by 56.07% to $70404.0 in 2025, then jumped by 789.28% to $626092.0 in 2026.
- Business Quant data shows QNTM's Research & Development at $626092.0 in Q1 2026, $70404.0 in Q4 2025, and $495223.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | 626,092.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 626,092.00 |
| Dec 31, 2025 | 70,404.00 |
| Sep 30, 2025 | 495,223.00 |
| Jun 30, 2025 | 549,197.00 |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 160,260.00 |
| Sep 30, 2024 | 744,802.00 |
| Jun 30, 2024 | 897,986.00 |
| Mar 31, 2024 | 160,260.00 |
| Sep 30, 2023 | 32,985.00 |
| Mar 31, 2023 | 2.31 Mn |
| Mar 31, 2022 | 937,052.00 |
| Jun 30, 2021 | 3.61 Mn |
| Sep 30, 2020 | 3.50 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Mar 31, 2020 | 226,299.20 |